Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KALV - KalVista Pharmaceuticals, Inc.
151 M
LAST VALUE
876.36%
2 YEAR CAGR
11.38%
5 YEAR CAGR
37.12%
10 YEAR CAGR